Investor News View all

Doseology Appoints Patrick W. Sills as Strategic Go-to-Market Advisor
Doseology Appoints Timothy Corkum as President & COO to Drive Strategic Expansion into the Stimulant Pouch Market
Doseology Closes $750,000 Non-Brokered Private Placement
Doseology Announces Amended Private Placement Unit Price
Doseology Announces Option Grant
Doseology Announces $1.2M Private Placement to Advance Commercialization
Doseology Appoints Chris Jackson, Founder of Qtrade, as Chief Executive Officer and a Director
Doseology Invests into the Multi-Billion-Dollar U.S. Modern Oral Stimulant Market
Executive Realignment at Doseology to Drive Future Expansion